Experience and Development of the Video-Assisted Thoracic Surgery Lobectomy Technique: Comparative Study With Conventional Surgery in Stage I Non-Small Cell Lung Cancer

Triviño-Cabrera, Alicia; Congregado, Miguel; Loscertales, Jesús; Jiménez-Merchán, Rafael; Vélez, Nathalie Pinos; Cózar, Fernando; Carmona-Soto, Patricia

doi:10.1016/j.arbr.2014.01.002

Cited by 3 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 Since then, the VATS has gained popularity in both lobectomies and pneumonectomies with better clinical outcomes as compared with traditional open surgery (TOS). 10 The potential benefits of VATS lobectomy contain decreased postoperative pain, less impairment in pulmonary function, reduced cytokine release, shorter chest tube duration, as well as shorter hospital stay. 11 Initial suggestions of the oncologic equivalence for resection of early-stage NSCLC have widely been disproven; because of limited experience, large sample size to examine the results for thoracoscopic resection for locally advanced and more complex tumors are still lacking.…”

Section: Introductionmentioning

confidence: 99%

Comparison of the Effects of Lobectomy on Immunologic Function Between Video-Assisted Thoracoscopic Surgery and Traditional Open Surgery for Non–Small-Cell Lung Cancer

Zhang

Ren

Liu

2016

American Journal of Therapeutics

View full text Add to dashboard Cite

To compare the effects of lobectomy on immunologic function between video-assisted thoracoscopic surgery (VATS) and traditional open surgery (TOS) for non-small-cell lung cancer (NSCLC). A total of 80 patients with NSCLC were recruited from Liaoning Cancer Hospital & Institute between June 2013 and August 2014. The participators were grouped into VATS and TOS at random. The levels of C-reactive protein, serum amyloid A, interleukin (IL) 6, and IL-2R were detected before operation, 24 hours, and 72 hours after operation. The number of peripheral blood lymphocytes and the proportion of CD4 T lymphocytes, CD8 T lymphocytes, and natural killer in lymphocytes of all patients should be detected before operation, 3 days, and 7 days after operation. The preoperative and postoperative quality of life assessment of patients with NSCLC was evaluated. All data were analyzed using SPSS 17.0 software. The blood loss and transfusion volume during operation in VATS group were obviously less than those in TOS group. The levels of CPR, serum amyloid A, IL-6, and IL-2R after operation were significantly higher as compared with those before operation. The postoperative proportions of CD4 T lymphocytes and natural killer in lymphocytes and the number of lymphocytes were decreased compared with those before operation. The proportion of CD8 T lymphocytes 7 days after operation in TOS group was clearly lower than that in VATS group. The postoperative quality of life was evidently higher compared with that after operation in VATS and TOS groups. In conclusion, when compared with TOS, VATS could decrease perioperative acute-phase reaction, lighten the restrain of immunologic function, and improve quality of life in patients with early-stage NSCLC, suggesting that VATS lobectomy is an appropriate method for patients with early-stage NSCLC as compared with TOS.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparison of the Effects of Lobectomy on Immunologic Function Between Video-Assisted Thoracoscopic Surgery and Traditional Open Surgery for Non–Small-Cell Lung Cancer

Zhang

Ren

Liu

2016

American Journal of Therapeutics

View full text Add to dashboard Cite

show abstract

“…VATS has become the method of choice for the management of many thoracic conditions, and advances in technology and surgical techniques have allowed even segmentectomies to be performed for selected patients with early lung cancer [23]. VATS lobectomy has become the preferred procedure for the surgical management of early‐stage lung cancer [5, 6, 9], with oncological outcomes similar to or better than those for open thoracotomy [7, 10]. In a recent meta‐analysis, Chen et al [8] reported that, for patients with clinical stage I NSCLC, VATS achieved better outcomes than open thoracotomy.…”

Section: Discussionmentioning

confidence: 99%

“…Video‐assisted thoracic surgery (VATS) lobectomy is now commonly used for the surgical management of early‐stage non‐small‐cell lung cancer (NSCLC), and numerous reports have confirmed its safety and efficacy, with oncological outcomes similar to those of open thoracotomy [1–10]. Compared with open thoracotomy, thoracoscopic lobectomy is associated with decreased morbidity, shorter chest tube duration, reduced length of hospital stay, decreased postoperative pain, improved preservation of pulmonary function, and shorter recovery time.…”

Section: Introductionmentioning

confidence: 99%

Management of the Pulmonary Artery during Video‐Assisted Thoracoscopic Left Upper Lobectomy

et al. 2014

View full text Add to dashboard Cite

show abstract

Optimal Approach to Lobectomy for Non-Small Cell Lung Cancer: Systemic Review and Meta-Analysis

MacDonald

Gilbert

et al. 2019

Innovations�(Phila)

View full text Add to dashboard Cite

Objective Video-assisted thoracic surgery (VATS) lobectomy was introduced over 25 years ago. More recently, the technique has been modified from a multiport video-assisted thoracic surgery (mVATS) to uniportal (uVATS) and robotic (rVATS), with proponents for each approach. Additionally most lobectomies are still performed using an open approach. We sought to provide evidence-based recommendations to help define the optimal surgical approach to lobectomy for early stage non-small cell lung cancer. Methods Systematic review and meta-analysis of articles searched without limits from January 2000 to January 2018 comparing open, mVATS, uVATS, and rVATS using sources Medline, Embase, and Cochrane Library were considered for inclusion. Articles were individually scrutinized by ISMICS consensus conference members, and evidence-based statements were created and consensus processes were used to determine the ensuing recommendations. The ACC/AHA Clinical Practice Guideline Recommendation Classification system was used to assess the overall quality of evidence and the strength of recommendations. Results and recommendations One hundred and forty-five studies met the predefined inclusion criteria and were included in the meta-analysis. Comparisons were analyzed between VATS and open, and between different VATS approaches looking at oncological outcomes (survival, recurrence, lymph node evaluation), safety (adverse events), function (pain, quality of life, pulmonary function), and cost-effectiveness. Fifteen statements addressing these areas achieved consensus. The highest level of evidence suggested that mVATS is preferable to open lobectomy with lower adverse events (36% versus 42%; 88,460 patients) and less pain (IIa recommendation). Our meta-analysis suggested that overall survival was better (IIb) with mVATS compared with open (71.5% versus 66.7% 5-years; 16,200 patients). Different VATS approaches were similar for most outcomes, although uVATS may be associated with less pain and analgesic requirements (IIb). Conclusions This meta-analysis supports the role of VATS lobectomy for non-small cell lung cancer. Apart from potentially less pain and analgesic requirement with uVATS, different minimally invasive surgical approaches appear to have similar outcomes.

show abstract

Experience and Development of the Video-Assisted Thoracic Surgery Lobectomy Technique: Comparative Study With Conventional Surgery in Stage I Non-Small Cell Lung Cancer

Cited by 3 publications

References 11 publications

Comparison of the Effects of Lobectomy on Immunologic Function Between Video-Assisted Thoracoscopic Surgery and Traditional Open Surgery for Non–Small-Cell Lung Cancer

Comparison of the Effects of Lobectomy on Immunologic Function Between Video-Assisted Thoracoscopic Surgery and Traditional Open Surgery for Non–Small-Cell Lung Cancer

Management of the Pulmonary Artery during Video‐Assisted Thoracoscopic Left Upper Lobectomy

Optimal Approach to Lobectomy for Non-Small Cell Lung Cancer: Systemic Review and Meta-Analysis

Contact Info

Product

Resources

About